A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.251.12 (2.6%)
NVS$53.630.55 (1.04%)
SNY$36.340.43 (1.2%)
GSK$38.530.41 (1.08%)
click here
Head and Neck News
Latest Head and Neck News
No Adverse Effects of Epoetin Alfa in Patients with Head and Neck Cancer Receiving Radiotherapy (12/1/2009)

Uninsured Have Higher Mortality from Head and Neck Cancer than Insured (11/25/2009)

Presence of Rash Associated with Improved Survival in Patients Receiving Adjuvant Erbitux® for Locally Advanced Head and Neck Cancer (11/16/2009)

H-R3 (Nimotuzumab) Enhances Radiation and Chemotherapy Responses in Advanced Head and Neck Cancer (11/11/2009)

Adjuvant Erbitux® May Improve Survival of High-risk Resected Head and Neck Cancer (11/11/2009)

Newsletters
Register in our member center today to receive a monthly newsletter with clinical news updates.
Learn More »
More on Head and Neck
Review the latest current topics and conference coverage on Head and Neck written by thought leaders.
Learn More »
Practice Resources
Learn how to have our news directly fed to your website.
Learn More »

Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.